Teleflex Subsidiary Faces Federal False Claims Investigation
Urology device developer NeoTract, which Teleflex purchased in 2017, is now under scrutiny for potential FCA violations.

Urology device developer NeoTract, which Teleflex purchased in 2017, is now under scrutiny for potential FCA violations.